SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3126Looks to me like someone is accumulating this in size.Micawber-7/20/2001
3125juneau_boy nice article on ISIP, but they did not get the stock symbol correct iMrluckyOne-7/19/2001
3124And this just in. Good, clear article. "Making Sense of Genta's Technjuneau_boy-7/19/2001
3123Isis Pharmaceuticals' GeneTrove Division Signs Deal With Celera Genomics To SemiBull-7/16/2001
3122Joint Effort to Investigate Gene Functions Celera Genomics (news/quote) and IsiSemiBull-7/16/2001
3121I can speak to patent litigation, the costs vs. benefits, but first need to knowSemiBull-7/9/2001
3120Anyone catch the call? I don't know that I have enough background to undersExtra Pale-7/9/2001
3119ISIP starts a patent infringement suit; CC in ~1 1/2 hours: >>CARLSBAD, Ctuck-7/9/2001
3118From the conference call I gather that the placebo error is common when doing loExtra Pale-6/25/2001
3117Did ISIP screw-up this study? "A factor that may have contributed to the hExtra Pale-6/25/2001
3116Isis Pharmaceuticals Initiates A Phase II Clinical Trial of Topical Isis 104838,SemiBull-6/21/2001
3115Early Hep C results: >>CARLSBAD, Calif., June 18 /PRNewswire/ -- In a Phatuck-6/18/2001
3114ISIS Pharmaceuticals Makes Statement Regarding ING Barings First Call Note biz.ySemiBull-6/12/2001
3113Wall Street Journal article...good PR By David P. Hamilton Of THE WALL STREET juneau_boy-6/7/2001
3112Isis Pharmaceuticals Appoints Richard K. Brown President of Its GeneTrove DivisiSemiBull-6/4/2001
3111It's nice to ISIP making slow but steady progress on most frontsKeith Fauci-5/26/2001
3110From MTSL: Antisense—big news, little splash Isis impressed us at last year’s AExtra Pale-5/26/2001
3109MTSL comments on ASCO/ISIS text at posts starting here: ragingbull.lycos.com TI2TI2, TechInvestorToo-5/25/2001
3108Friday May 25, 8:00 am Eastern Time Press Release SOURCE: Isis Pharmaceuticalsbetone-5/25/2001
3107This is getting real interesting...this deal further solidifies ISIS' patentjuneau_boy-5/25/2001
3106New deal; somewhat surprised at the lack of corresponding action in the stock: tuck-5/23/2001
3105Topical Antisense Therapy Improves Psoriasis Disease Pathology In Animal Model, SemiBull-5/14/2001
3104ASCO: >>SAN FRANCISCO, May 14 /PRNewswire/ -- ISIS 3521, an investigationtuck-5/14/2001
3103MIT analysis of patent positions...pretty interesting, at least to me, as I havejuneau_boy-5/10/2001
3102"This press release contains forward-looking statements pertaining to Ibis SemiBull-5/8/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News